SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-22-018843
Filing Date
2022-12-20
Accepted
2022-12-20 17:30:23
Documents
13
Period of Report
2022-12-14
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K rsls-20221214x8k.htm   iXBRL 8-K 71475
2 EX-10.1 rsls-20221214xex10d1.htm EX-10.1 244760
  Complete submission text file 0001558370-22-018843.txt   476968

Data Files

Seq Description Document Type Size
3 EX-101.SCH rsls-20221214.xsd EX-101.SCH 3107
4 EX-101.LAB rsls-20221214_lab.xml EX-101.LAB 15242
5 EX-101.PRE rsls-20221214_pre.xml EX-101.PRE 9783
7 EXTRACTED XBRL INSTANCE DOCUMENT rsls-20221214x8k_htm.xml XML 4715
Mailing Address 1001 CALLE AMANECER SAN CLEMENTE CA 92673
Business Address 1001 CALLE AMANECER SAN CLEMENTE CA 92673 949-429-6680
ReShape Lifesciences Inc. (Filer) CIK: 0001427570 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37897 | Film No.: 221475891
SIC: 3841 Surgical & Medical Instruments & Apparatus